Udo Klein - Net Worth and Insider Trading

Udo Klein Net Worth

The estimated net worth of Udo Klein is at least $105 dollars as of 2024-09-20. Udo Klein is the Senior Vice President of R&D of CASI Pharmaceuticals Inc and owns about 16 shares of CASI Pharmaceuticals Inc (CASI) stock worth over $105. Details can be seen in Udo Klein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Udo Klein has not made any transactions after 2004-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Udo Klein

To

Udo Klein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Udo Klein owns 1 companies in total, including CASI Pharmaceuticals Inc (CASI) .

Click here to see the complete history of Udo Klein’s form 4 insider trades.

Insider Ownership Summary of Udo Klein

Ticker Comapny Transaction Date Type of Owner
CASI CASI Pharmaceuticals Inc 2004-09-03 Senior Vice President of R&D

Udo Klein Latest Holdings Summary

Udo Klein currently owns a total of 1 stock. Udo Klein owns 16 shares of CASI Pharmaceuticals Inc (CASI) as of September 3, 2004, with a value of $105.

Latest Holdings of Udo Klein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CASI CASI Pharmaceuticals Inc 2004-09-03 16 6.54 105

Holding Weightings of Udo Klein


Udo Klein Form 4 Trading Tracker

According to the SEC Form 4 filings, Udo Klein has made a total of 0 transactions in CASI Pharmaceuticals Inc (CASI) over the past 5 years. The most-recent trade in CASI Pharmaceuticals Inc is the acquisition of 16 shares on September 3, 2004, which cost Udo Klein around $2,682.

Insider Trading History of Udo Klein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Udo Klein Trading Performance

GuruFocus tracks the stock performance after each of Udo Klein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Udo Klein is 49.67%. GuruFocus also compares Udo Klein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Udo Klein within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Udo Klein's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Udo Klein

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.89 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.29 LIMIT LIMIT LIMIT LIMIT LIMIT

Udo Klein Ownership Network

Ownership Network List of Udo Klein

No Data

Ownership Network Relation of Udo Klein

Insider Network Chart

Udo Klein Owned Company Details

What does CASI Pharmaceuticals Inc do?

Who are the key executives at CASI Pharmaceuticals Inc?

Udo Klein is the Senior Vice President of R&D of CASI Pharmaceuticals Inc. Other key executives at CASI Pharmaceuticals Inc include director & 10 percent owner & Chairman and CEO Wei-wu He , Chief Financial Officer Weihao Xu , and President Larry Zhang .

CASI Pharmaceuticals Inc (CASI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CASI Pharmaceuticals Inc (CASI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CASI Pharmaceuticals Inc (CASI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CASI Pharmaceuticals Inc (CASI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CASI Pharmaceuticals Inc Insider Transactions

No Available Data

Udo Klein Mailing Address

Above is the net worth, insider trading, and ownership report for Udo Klein. You might contact Udo Klein via mailing address: 9640 Medical Center Dr, Rockville Md 20850.

Discussions on Udo Klein

No discussions yet.